|| A few years ago, in 1985, I worked on the ganciclovir study, and that
drug finally was approved by the FDA for the treatment of CMV retinitis.
Then, in 1989, I managed the foscarnet study. The data from the studies
at the NIH was very influential in obtaining FDA approval. I have been
fortunate to be involved in studies of a number of drugs that have received
FDA approval. It is a nice reward, after the hard work of gathering the
data and getting it organized, that ultimately, there are millions of
people getting this drug that would not ordinarily have done so because
we have done a good job.